Pursuant to Regulation 30 read with Schedule III Part A(A) and in compliance of Regulation 47(l)(b) of SEBI (LODR) Regulations, 2015, Syncom Formulations (India) has informed regarding extract of Standalone Un-Audited Quarterly Financial Results for the Quarter ended 30th June, 2021 was approved in 02/2021-22 Meeting of Board of Directors held on Saturday, 14th August, 2021 at 2.00 pm at the Corporate Office of the company at 207, Saket Nagar, Indore (M.P) 452018. The company has enclosed the newspaper advertisement published on 15/08/2021 in Free Press Journal English edition and Marathi (vernacular) Newspaper.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1935.25 |
| Dr. Reddys Labs. | 1245.50 |
| Cipla | 1438.75 |
| Zydus Lifesciences | 1150.50 |
| Lupin | 2496.05 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: